BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3938043)

  • 1. [Inhibitory effect of PGE1 on the liberation of insulin induced by glibenclamide].
    Villar A; D'Ocón MP; Anselmi E
    Rev Esp Fisiol; 1985 Dec; 41(4):451-5. PubMed ID: 3938043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PGE2 on sulfonylurea induced insulin release.
    Villar A; Ivorra MD; Anselmi E
    J Physiol (Paris); 1987; 82(1):12-7. PubMed ID: 3123643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glibenclamide partly reverses monesin inhibition of insulin secretion, in vivo.
    Casu A; Camogliano L
    Life Sci; 1993; 53(11):953-60. PubMed ID: 8366762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of PGE1 on glucose induced insulin release in isolated islets of Langerhans.
    D'Ocon P; del Río H; Villar A
    Rev Esp Fisiol; 1988 Jun; 44(2):151-5. PubMed ID: 3057545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of glibenclamide on glucagon and insulin secretions studied on isolated and perfused pancreas of the rat].
    Loubatières AL; Loubatières-Mariani MM; Chapal J; Blayac JP
    C R Seances Soc Biol Fil; 1975; 169(6):1568-71. PubMed ID: 132249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic secretion in rats treated with intra-aortic prostaglandin E1].
    García-Casarrubios A; Carbonell I; Alonso de Armiño V; Frasquet I
    Rev Esp Fisiol; 1983 Mar; 39(1):77-81. PubMed ID: 6346415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Morpholinosydnonimine as instigator of a glibenclamide-sensitive reduction in the insulin secretory rate.
    Antoine MH; Ouedraogo R; Hermann M; Segooris J; Herchuelz A; Lebrun P
    Biochem Pharmacol; 1997 Apr; 53(8):1211-3. PubMed ID: 9175727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System.
    Lundquist I; Mohammed Al-Amily I; Meidute Abaraviciene S; Salehi A
    PLoS One; 2016; 11(11):e0165668. PubMed ID: 27820841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucagon and pentagastrin on glibenclamide-induced insulin release.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1980 Jul; 109(3):261-4. PubMed ID: 6778077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by IBMX, fasting and experimental diabetes of glibenclamide-induced islet hormone release from the perfused rat pancreas.
    Ostenson CG; Grill V; Nylén A; Efendić S
    Diabete Metab; 1983 Mar; 9(1):58-65. PubMed ID: 6189748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats.
    Berridge TL; Doxey JC; Roach AG
    Eur J Pharmacol; 1992 Mar; 213(2):213-8. PubMed ID: 1355734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion.
    Basabe JC; Farina JM; Chieri RA
    Horm Metab Res; 1976 Nov; 8(6):413-9. PubMed ID: 12072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of PGE1 and E2 on glucose induced insulin release.
    Villar del Fresno A; D'Ocon MP; Ivorra MD; Anselmi E
    Rev Esp Fisiol; 1984 Sep; 40(3):385-7. PubMed ID: 6395237
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E1: stimulation of somatostatin and insulin responses to glucose from the isolated perfused rat pancreas.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Ishida H; Imura H
    Prostaglandins Leukot Med; 1982 Jun; 8(6):593-7. PubMed ID: 6125951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis.
    Lehtihet M; Welsh N; Berggren PO; Cook GA; Sjoholm A
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E438-46. PubMed ID: 12684219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the glucose induced insulin release by somatostatin in the isolated perfused rat pancreas. Action of cyclic AMP, glucagon and glibenclamide.
    Osorio J; Campillo JE; de los Arcos JG; Pagés I; Rodríguez E; Marasco M; Melani F
    Rev Esp Fisiol; 1976 Sep; 32(3):211-6. PubMed ID: 185668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modifications induced in post-prandial glycemia and insulinemia by treatment with glibenclamide and with a combination of glibenclamide and phenformin].
    Specchia G; Tenconi M; Ray M; Degna CT
    Farmaco Prat; 1974 May; 29(5):251-63. PubMed ID: 4210965
    [No Abstract]   [Full Text] [Related]  

  • 19. Glyburide enhances insulin gene expression and glucose-induced insulin release in isolated rat islets.
    Yamato E; Ikegami H; Tahara Y; Fukuda M; Cha T; Kawaguchi Y; Fujioka Y; Noma Y; Shima K; Ogihara T
    Biochem Biophys Res Commun; 1994 Feb; 199(1):327-33. PubMed ID: 8123030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level.
    Alarcon C; Wicksteed B; Rhodes CJ
    Diabetologia; 2006 Dec; 49(12):2920-9. PubMed ID: 17053883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.